Pacira | Kostnadene For Salg

Cost Of Sales Endring Dato
Astellas Pharma JPY 75.9B 1.49B 2023-12
Bristol-Myers Squibb USD 2.93B 225M 2024-03
Ironwood Pharmaceuticals USD 0 0 2021-12
J&J USD 6.51B 287M 2024-03
Ligand Pharmaceuticals USD 2.88M 1.24M 2024-03
Pacira USD 47.42M 276K 2024-03
Perrigo USD 724.4M 5.2M 2024-03
Pfizer USD 3.38B 3.29B 2024-03
Supernus Pharmaceuticals USD 16.31M 3.32M 2024-03
Teva Pharmaceutical Industries USD 2.05B 88M 2024-03
Xeris Pharmaceuticals USD 5.97M 1.6M 2024-03
Zoetis USD 643M 83M 2024-03



Pacira Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.